XML 47 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Reporting (Tables)
12 Months Ended
Dec. 31, 2013
Segment Reporting (Tables) [Abstract]  
Reconciliation of Revenue from Segments to Consolidated [Table Text Block]
 
 
Year Ended December 31,
(in millions)
 
2013
 
2012
 
2011
Net sales
 
 
 
(restated)
 
(restated)
Interventional Cardiology
 
$
2,055

 
$
2,179

 
$
2,444

Peripheral Interventions
 
812

 
769

 
713

Cardiovascular
 
2,867

 
2,948

 
3,157

 
 
 
 
 
 
 
Cardiac Rhythm Management
 
1,919

 
1,927

 
2,072

Electrophysiology
 
157

 
147

 
145

Rhythm Management
 
2,076

 
2,074

 
2,217

 
 
 
 
 
 
 
Endoscopy
 
1,331

 
1,242

 
1,158

Urology and Women's Health
 
513

 
496

 
491

Neuromodulation
 
454

 
367

 
336

MedSurg
 
2,298

 
2,105

 
1,985

Net sales allocated to reportable segments
 
7,241

 
7,127

 
7,359

Sales generated from business divestitures
 
58

 
122

 
140

Impact of foreign currency fluctuations
 
(156
)
 

 
123

 
 
$
7,143

 
$
7,249

 
$
7,622

Reconciliation of depreciation by reportable segment to total [Table Text Block]
 
 
Year Ended December 31,
(in millions)
 
2013
 
2012
 
2011
Depreciation expense
 
 
 
(restated)

 
(restated)

Cardiovascular
 
$
111

 
$
106

 
$
116

Rhythm Management
 
99

 
108

 
105

MedSurg
 
73

 
74

 
73

Depreciation expense allocated to reportable segments
 
283

 
288

 
294

Impact of foreign currency fluctuations
 
(4
)
 

 
2

 
 
$
279

 
$
288

 
$
296


Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
 
 
Year Ended December 31,
(in millions)
 
2013
 
2012
 
2011
Income (loss) before income taxes
 
 
 
(restated)
 
(restated)
Cardiovascular
 
$
710

 
$
739

 
$
829

Rhythm Management
 
232

 
242

 
320

MedSurg
 
724

 
637

 
565

Operating income allocated to reportable segments
 
1,666

 
1,618

 
1,714

Corporate expenses and currency exchange
 
(314
)
 
(258
)
 
(254
)
Goodwill and intangible asset impairment charges and acquisition-, divestiture-, litigation-, and restructuring-related net charges
 
(822
)
 
(4,833
)
 
(135
)
Amortization expense
 
(410
)
 
(395
)
 
(421
)
Operating income (loss)
 
120

 
(3,868
)
 
904

Other expense, net
 
(343
)
 
(239
)
 
(262
)
 
 
$
(223
)
 
$
(4,107
)
 
$
642


Reconciliation of Assets from Segment to Consolidated [Table Text Block]
 
 
As of December 31,
(in millions)
 
2013
 
2012
Total assets
 
 
 
(restated)

Cardiovascular
 
$
1,545

 
$
1,535

Rhythm Management
 
1,343

 
1,350

MedSurg
 
1,026

 
967

Total assets allocated to reportable segments
 
3,914

 
3,852

Goodwill
 
5,693

 
5,973

Other intangible assets, net
 
5,950

 
6,289

All other corporate assets
 
1,014

 
1,040

 
 
$
16,571

 
$
17,154

Reconciliation of sales by division and region to consolidated [Table Text Block]
 
 
Year Ended December 31,
(in millions)
 
2013
 
2012
 
2011
Net sales
 
 
 
 
 
 
Interventional Cardiology
 
$
1,997

 
$
2,179

 
$
2,495

Cardiac Rhythm Management
 
1,886

 
1,908

 
2,087

Endoscopy
 
1,300

 
1,252

 
1,187

Peripheral Interventions
 
789

 
774

 
731

Urology and Women’s Health
 
505

 
500

 
498

Neuromodulation
 
453

 
367

 
336

Electrophysiology
 
155

 
147

 
147

 
 
7,085

 
7,127

 
7,481

Sales generated from divested businesses
 
58

 
122

 
141

 
 
$
7,143

 
$
7,249

 
$
7,622

 
 
 
 
 
 
 
United States
 
$
3,743

 
$
3,756

 
$
4,010

Japan
 
744

 
931

 
951

Other countries
 
2,598

 
2,440

 
2,520

 
 
7,085

 
7,127

 
7,481

Sales generated from divested businesses
 
58

 
122

 
141

 
 
$
7,143

 
$
7,249

 
$
7,622

Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]
 
 
As of December 31,
(in millions)
 
2013
 
2012
 
2011
Long-lived assets
 
 
 
 
 
 
United States
 
$
998

 
$
1,065

 
$
1,141

Ireland
 
240

 
252

 
231

Other foreign countries
 
308

 
247

 
298

Property, plant and equipment, net
 
1,546

 
1,564

 
1,670

Goodwill
 
5,693

 
5,973

 
9,761

Other intangible assets, net
 
5,950

 
6,289

 
6,473

 
 
$
13,189

 
$
13,826

 
$
17,904